RecoupIQ provides business intelligence from public UK records. Nothing here constitutes financial advice, a regulated credit assessment, or a regulated activity under FSMA 2000. Evidence indicators summarise available records and are not credit decisions. ICO ZC077511. Privacy · Terms · Corrections
This page keeps the public record visible while making the next decision clear. It confirms the legal entity, shows the current evidence posture, and points you to the deeper check only when you need it.
Confirm legal entity
Check the number and registered office before you rely on this page.
Registered office: BSBMTCT DATA REGISTRY C/O GUY'S HOSPITAL, LONDON, SE1 9RT, ENGLAND, SE1 9RT
Published profile snapshot date: 15 Oct 2026. This page shows selected public evidence, not a guarantee of payment or solvency.
Register status
Active
Companies House record
Register age
18 years
Since 2008-01-03
Public signals
1 selected signal
Displayed checks only
Core statutory intelligence compiled from Companies House, filed iXBRL statutory accounts, and the register of charges.
Available public evidence
Amber means selected public-record signals deserve verification before a material decision. Scale: red means non-normal status, and green means no selected warning found. It is not a credit score or payment prediction.
Recommended next step: Verify the selected signals before increasing credit, committing spend, or extending terms.
Warning Signals Identified
Selected public-record signals from 15 Oct 2026; verify current source and context before acting.
Before you commit
The Quick Check turns this public record into a source-linked PDF with the evidence available, the warning signals that deserve attention, and the exact questions to verify before extending credit or signing contracts.
What the record shows
Verified filings, accounts & charges
What to verify next
Recommended checks & protective terms
Select report depth (instant 1-click checkout · no account required)
Forensic Report, £167.00
We pull deeper public-record evidence the moment you order: director history, connected companies, filed accounts, charges, sector context, and source-linked findings. Use the report to decide what to verify, what terms to discuss, and when to review the relationship. PDF in your inbox within minutes.
See a sample report →“This product I found excellent, delivered exactly what I wanted and in a timely manner too.”
Elvis Serkedi · Trustpilot
Check first. Get change alerts for this company, free.
We read the registers daily. If BRITISH SOCIETY OF BLOOD AND MARROW TRANSPLANTATION AND CELLULAR THERAPY files an insolvency notice, picks up a Gazette entry, or its public-record position changes, you’ll know the same day.
Used only to send change alerts about this company, for 90 days. One-click unsubscribe in every email. No marketing.
Companies House Officer Record
DIGNAN, FIONA LOUISE
director · Appointed 2025-03-04
POTTER, VICTORIA THERESE
director · Appointed 2024-12-31
RICHARDSON, DEBORAH SUSAN
director · Appointed 2020-01-01
OLAVARRIA, EDUARDO
director · Appointed 2021-07-22
Statutory Register Records
Company Status
Active
Company Type
PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption)
Incorporated
2008-01-03(18 yrs)
Registered Office Address
BSBMTCT DATA REGISTRY C/O GUY'S HOSPITAL, LONDON, SE1 9RT
Industry Classification (SIC)
Filing Deadlines & Compliance Status
Last Accounts Filed
2024-12-31(TOTAL EXEMPTION FULL)
Accounts Next Due
OverdueBeneficial Ownership Record
Dr Fiona Louise Dignan
Source: Companies House PSC register. Full ownership chain analysis is available in the Decision Brief.
Evidence Boundary
Source-backed visual
Each bar shows the module contribution available in this published profile. A missing bar is an evidence gap, not a favourable result.
Official status
25% of coverage measure
Available
Registered address
Forensic Overview
BRITISH SOCIETY OF BLOOD AND MARROW TRANSPLANTATION AND CELLULAR THERAPY is an established pri/lbg/nsc (private, limited by guarantee, no share capital, use of 'limited' exemption) based in LONDON, incorporated in January 2008 and 18 years on the register. Its primary registered activity is specialists medical practice activities.
Filing obligations show a concern: accounts are overdue at Companies House (last filed 21 months ago as accounts), and the confirmation statement is up to date.
On charges and ownership: no charges are registered at Companies House; 1 person with significant control recorded (Dr Fiona Louise Dignan).
Public-register risk signals for BRITISH SOCIETY OF BLOOD AND MARROW TRANSPLANTATION AND CELLULAR THERAPY: traded previously as BRITISH SOCIETY OF BLOOD MARROW TRANSPLANTATION.
A paid RecoupIQ report for BRITISH SOCIETY OF BLOOD AND MARROW TRANSPLANTATION AND CELLULAR THERAPY adds a source-linked review of the available evidence and a prioritised verification plan, delivered as a PDF within minutes.
Source: Companies House public register, filed accounts (iXBRL), The Gazette, and HMRC. Synced daily.
Search across 5.4 million registered UK companies for insolvency petitions, Gazette notices, CCJs, and director cross-directorships in real time.
Knowledge Base & Diligence FAQ
Legal Methodology & Evidence Integrity
How we work this out. Every claim is built from public UK records: Companies House (filings, officers, charges register), filed accounts (XBRL), The Gazette corporate-insolvency notices, and HMRC’s Public Deliberate Defaulters register. Paid analysis may add derived filing, financial, network, and continuity context where the underlying evidence is available. Derived outputs are labelled with their inputs, source dates, and limitations; they are not guarantees of payment or regulated credit decisions. Source data is published under the Open Government Licence v3.0.
Honest opinion. Aggregate signals only. Specific named claims about still-trading companies are framed as percentile and evidence-based observation under the Defamation Act 2013 §3 honest-opinion defence. Right of reply: any company can email contact@recoup-iq.tech with corrections to filed data.
Need complete cross-director insolvency & solvency tracking?
Unlock the source-linked Quick Check (£29) or full Forensic Dossier (£167.00) with director dissolution histories, connected-company contagion, and credit decision guidance.
Evidence availability score
Partial evidence set. 4 of 7 defined modules assessed. This is not a credit score, probability of default, or clearance to trade. Source: 15 Oct 2026.
Permanent PDF record
Delivered to your email in minutes
Choose the depth that matches your decision
Commercial use cases
Frequently asked buyer questions
No. The traffic light describes available public evidence and selected warnings. It is not a probability of default, payment guarantee, or clearance to trade.
Missing evidence stays visible as a coverage limit. It cannot become a green result, and the report states what should be verified elsewhere.
One source-linked PDF for this company, with findings, evidence dates, questions to verify, and terms to discuss. Delivery is within minutes of purchase.
KAUR, HARPREET
director · Appointed 2023-01-03
Source: RecoupIQ's current Companies House officer snapshot. Use the source link below to check that these facts match the official register. A paid report can add full appointment history, prior companies, and network connections.
2026-09-30
Confirmation Statement
Due 2027-01-13
Last filed 2025-12-30
Accounts Age
Filed 21 months ago
Previously Known As
10% of coverage measure
Available
Filing record
20% of coverage measure
Available
Confirmation statement
15% of coverage measure
Available
Filed financial snapshot
15% of coverage measure
Not available
Official payment-practice return
10% of coverage measure
Not available
Corporate relationships
5% of coverage measure
Not available
Source: published public-record profile. Profile date: 15 Oct 2026. Coverage availability only, not a credit score.
The 70/100 score measures evidence availability only. Missing evidence is not treated as low risk. Published snapshot date: 15 Oct 2026.
Check Another Company
Verify another UK debtor, supplier, or counterparty.
On this page
